vs
BioNTech SE（BNTX）与Fifth Third Bancorp（FITB）财务数据对比。点击上方公司名可切换其他公司
Fifth Third Bancorp的季度营收约是BioNTech SE的1.0倍（$1.5B vs $1.5B），Fifth Third Bancorp净利率更高（47.7% vs -1.9%，领先49.6%）
BioNTech SE是总部位于德国美因茨的跨国生物技术企业，专注于免疫疗法及疫苗研发工作，核心研究方向覆盖肿瘤、传染性疾病等医疗领域，相关技术处于全球生物医药行业领先水平。
Fifth Third Bancorp是总部位于美国俄亥俄州辛辛那提的银行控股集团，为美国大型银行之一，位列《财富》美国500强第321位。旗下银行在全美12个州共运营1087家分行及2400台自动柜员机，服务覆盖多区域市场。
BNTX vs FITB — 直观对比
营收规模更大
FITB
是对方的1.0倍
$1.5B
净利率更高
FITB
高出49.6%
-1.9%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $1.5B |
| 净利润 | $-28.7M | $730.0M |
| 毛利率 | — | — |
| 营业利润率 | -3.1% | 59.7% |
| 净利率 | -1.9% | 47.7% |
| 营收同比 | — | 6.4% |
| 净利润同比 | — | 17.7% |
| 每股收益（稀释后） | — | $1.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BNTXFITB
| Q4 25 | — | $1.5B | ||
| Q3 25 | $1.5B | $1.5B | ||
| Q2 25 | $260.8M | $1.5B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | $1.2B | — |
净利润BNTXFITB
| Q4 25 | — | $730.0M | ||
| Q3 25 | $-28.7M | $649.0M | ||
| Q2 25 | $-386.6M | $628.0M | ||
| Q1 25 | — | $515.0M | ||
| Q4 24 | — | $620.0M | ||
| Q3 24 | $198.1M | — |
营业利润率BNTXFITB
| Q4 25 | — | 59.7% | ||
| Q3 25 | -3.1% | 55.1% | ||
| Q2 25 | -192.1% | 54.0% | ||
| Q1 25 | — | 45.4% | ||
| Q4 24 | — | 53.3% | ||
| Q3 24 | 0.8% | — |
净利率BNTXFITB
| Q4 25 | — | 47.7% | ||
| Q3 25 | -1.9% | 42.7% | ||
| Q2 25 | -148.2% | 42.0% | ||
| Q1 25 | — | 35.8% | ||
| Q4 24 | — | 43.1% | ||
| Q3 24 | 15.9% | — |
每股收益（稀释后）BNTXFITB
| Q4 25 | — | $1.03 | ||
| Q3 25 | — | $0.91 | ||
| Q2 25 | — | $0.88 | ||
| Q1 25 | — | $0.71 | ||
| Q4 24 | — | $0.85 | ||
| Q3 24 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | — |
| 总债务越低越好 | — | $13.6B |
| 股东权益账面价值 | — | $21.7B |
| 总资产 | — | $214.4B |
| 负债/权益比越低杠杆越低 | — | 0.63× |
8季度趋势，按日历期对齐
总债务BNTXFITB
| Q4 25 | — | $13.6B | ||
| Q3 25 | — | $13.7B | ||
| Q2 25 | — | $14.5B | ||
| Q1 25 | — | $14.5B | ||
| Q4 24 | — | $14.3B | ||
| Q3 24 | — | — |
股东权益BNTXFITB
| Q4 25 | — | $21.7B | ||
| Q3 25 | — | $21.1B | ||
| Q2 25 | — | $21.1B | ||
| Q1 25 | — | $20.4B | ||
| Q4 24 | — | $19.6B | ||
| Q3 24 | — | — |
总资产BNTXFITB
| Q4 25 | — | $214.4B | ||
| Q3 25 | — | $212.9B | ||
| Q2 25 | — | $210.0B | ||
| Q1 25 | — | $212.7B | ||
| Q4 24 | — | $212.9B | ||
| Q3 24 | — | — |
负债/权益比BNTXFITB
| Q4 25 | — | 0.63× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | 0.69× | ||
| Q1 25 | — | 0.71× | ||
| Q4 24 | — | 0.73× | ||
| Q3 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $929.0M |
| 自由现金流经营现金流 - 资本支出 | — | $765.0M |
| 自由现金流率自由现金流/营收 | — | 50.0% |
| 资本支出强度资本支出/营收 | — | 10.7% |
| 现金转化率经营现金流/净利润 | — | 1.27× |
| 过去12个月自由现金流最近4个季度 | — | $3.9B |
8季度趋势，按日历期对齐
经营现金流BNTXFITB
| Q4 25 | — | $929.0M | ||
| Q3 25 | — | $1.0B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | — | $-101.0M | ||
| Q3 24 | — | — |
自由现金流BNTXFITB
| Q4 25 | — | $765.0M | ||
| Q3 25 | — | $886.0M | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $-246.0M | ||
| Q3 24 | — | — |
自由现金流率BNTXFITB
| Q4 25 | — | 50.0% | ||
| Q3 25 | — | 58.3% | ||
| Q2 25 | — | 77.8% | ||
| Q1 25 | — | 77.7% | ||
| Q4 24 | — | -17.1% | ||
| Q3 24 | — | — |
资本支出强度BNTXFITB
| Q4 25 | — | 10.7% | ||
| Q3 25 | — | 10.5% | ||
| Q2 25 | — | 9.6% | ||
| Q1 25 | — | 8.1% | ||
| Q4 24 | — | 10.1% | ||
| Q3 24 | — | — |
现金转化率BNTXFITB
| Q4 25 | — | 1.27× | ||
| Q3 25 | — | 1.61× | ||
| Q2 25 | — | 2.08× | ||
| Q1 25 | — | 2.39× | ||
| Q4 24 | — | -0.16× | ||
| Q3 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
